Concepedia

Publication | Open Access

HERMIONE: a randomized Phase 2 trial of MM-302 plus trastuzumab versus chemotherapy of physician’s choice plus trastuzumab in patients with previously treated, anthracycline-naïve, HER2-positive, locally advanced/metastatic breast cancer

DOIFull Paper Access

153

Citations

39

References

2016

Year

Kathy D. Miller, Javier Cortés, Sara A. Hurvitz, Ian E. Krop, Debu Tripathy, Sunil Verma, Kaveh Riahi, Joseph G. Reynolds, Thomas J. Wickham, István Molnár,
BMC Cancer

Abstract

Clinicaltrials.gov identifier: NCT02213744 . Registration date: 06AUG2014.

References

YearCitations

Page 1